Amy C Degnim MD
Breast, Surgical Oncology (Other than Breast)
Associate Professor, Surgery, Mayo Medical School
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Degnim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsResidency, Surgery, 1991 - 1998
University of North Carolina at Chapel Hill School of MedicineClass of 1991
Certifications & Licensure
MN State Medical License 2003 - 2026
MI State Medical License 2002 - 2006
MA State Medical License 1998 - 2003
NC State Medical License 1991 - 2003
American Board of Surgery Surgery
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise (CE), GE Healthcare, 2013-2014
- CMS Meaningful Use Stage 1 Certification Centricity Enterprise, GE Healthcare, 2013-2014
- CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2013-2014
Clinical Trials
- Trial of Drain Antisepsis After Tissue Expander Breast Reconstruction Start of enrollment: 2011 May 01
- Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast Start of enrollment: 2017 May 31
- Neoadjuvant Multi-epitope HER2 Peptide Vaccine in Patients With HER2-expressing DCIS Start of enrollment: 2019 May 01
Publications & Presentations
PubMed
- Multi‑scale immune and spatial profiling of sclerosing adenosis and surrounding breast tissue identifies an immune‑cold field phenotype associated with breast cancer r...Nicole Cruz-Reyes, Hongling Liang, Melody Stallings-Mann, Laura Pacheco-Spann, Bryan M McCauley
Breast Cancer Research. 2026-05-02 - Epidermal Growth Factor Receptor/KIT-Linked Proliferative Bias in Normal Breast Lobules from Matched Non-Hispanic Black and White Women Is Rapidly Reversible by Recept...Joshua W Ogony, Nicole Cruz-Reyes, Laura Pacheco-Spann, Amanda Arnold, Sarah McLaughlin
The American Journal of Pathology. 2026-05-01 - The Human Male Mammary Gland has Similar Epithelial Populations to Female but Distinct Composition and Transcriptional Properties.M-Iliana Ibañez-Rios, Syed Mohammed Musheer Aalam, Megan L Ritting, Ashlyn Jore, Keyur Chaludia
Biorxiv. 2026-03-31
Journal Articles
- Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant ChemotherapyJames W Jakub, Amy C Degnim, Tina J Hieken, Judy C Boughey, Annals of Surgical Oncology
Press Mentions
The Race to Make a Vaccine for Breast CancerOctober 6th, 2022- Getting Closer to a Vaccine for CancerJune 14th, 2022
Predicting a Woman’s Risk for Breast Cancer Following a BiopsySeptember 14th, 2020
Grant Support
- Involution-based biomarkers of breast cancer riskMAYO CLINIC JACKSONVILLE2020–2025
- Biomarkers to Improve Targeting of Breast Cancer Prevention in Women with Atypical HyperplasiaMAYO CLINIC ROCHESTER2020–2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
